Corbett, J. W., Ko, S. S., Rodgers, J. D., Jeffrey, S., Bacheler, L. T., Klabe, R. M., . . . Erickson-Viitanen, S. K. (1999). Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1. American Society for Microbiology (ASM).
Chicago Style CitationCorbett, Jeffrey W., et al. Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1. American Society for Microbiology (ASM), 1999.
Cita MLACorbett, Jeffrey W., et al. Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1. American Society for Microbiology (ASM), 1999.